Tag: the war on (some) drugs

US Judge Hints He May Release Prince Harry’s Immigration Files, as Embattled British Royal Is Suspected of Lying on Visa Application About Past Drug Use

While his ties to England seem to have been severed for the most part, the prodigal son of King Charles, Prince Harry, is now involved in a lawsuit aiming to release his US immigration files to the public—a move that could end up seeing him turned away from his new chosen home.

A US federal judge hinted yesterday (5) that he is ‘likely’ to order the release of Harry’s immigration documents.

These files are expected to reveal if the Duke of Sussex was lawfully issued a visa or if he could now be subject to deportation for lying to US authorities about his admitted past drug use.

US District Court Judge for the District of Columbia Carl J. Nichols decided this during a hearing for a case brought by lawyers at the Heritage Foundation.

The conservative group is suing the Department of Homeland Security to compel the release of Harry’s records.

The New York Post reported:

“’To the maximum extent possible, I’m required to make public everything that can be made public’, Nichols told both parties, adding that he had to take care any disclosures do not violate US privacy laws shielding the Duke.

‘I’m going to take this in stages’, Nichols added at the end of the hearing, indicating that he would allow the government to ‘submit proposed redactions’ in order for him to ‘analyze’ whether Harry properly attested to cocaine, cannabis and psychedelic mushrooms abuse, as detailed in his 2023 memoir ‘Spare’.”

Keep reading

Colombian president calls for cocaine to be legalised worldwide and says it’s ‘no worse than whisky’

Colombia’s socialist president has said cocaine ‘is no worse than whisky’ and is only illegal because it comes from Latin America – as he called for the illicit drug to be legalised around the world. 

Colombia is the world’s biggest cocaine producer and exporter, mainly to the United States and Europe, and has spent decades fighting against drug trafficking. 

President Gustavo Petro’s remarks came during a live broadcast of a government meeting on Tuesday, in which he also claimed that cocaine is being scapegoated by American politicians. 

He stated that the illicit drug ‘is illegal because it is made in Latin America, not because it is worse than whisky.’

‘Scientists have analyzed this. Cocaine is no worse than whisky,’ he added, suggesting that the global cocaine industry could be ‘easily dismantled’ if the drug were legalized worldwide.

‘If you want peace, you have to dismantle the business (of drug trafficking),’ he said.

‘It could easily be dismantled if they legalize cocaine in the world. It would be sold like wine.’

Petro also pointed out that fentanyl ‘is killing Americans and it is not made in Colombia’, referring to the opioid responsible for around 75,000 deaths in the United States a year, according to official data.

Keep reading

Texas Lt. Gov. Touts Poll Result Backing Hemp Crackdown While Ignoring Support For Marijuana Legalization In Same Survey

Texas Lt. Gov. Dan Patrick (R) this week emphasized a survey result showing that more than half (55 percent) of Texans want the state to rein its largely unregulated market for hemp-derived THC. At the same time, however, he seemed to ignore the survey’s other findings: that even more Texans want the state to legalize and regulate marijuana for both medical and adult use.

“This is a huge polling number on the issue of banning THC,” Patrick said Tuesday on social media, zeroing in on hemp-derived THC products that are widely available across the state. “Texans see these stores everywhere: in their neighborhoods and especially around schools where children have easy access. People simply don’t want them around.”

“Once the facts are out in the open,” he continued, “there is no doubt these public polling numbers will rise as more Texans demand a ban on these dangerous products.”

Rather than an outright ban on THC, however, the broader results of the University of Houston’s Hobby School of Public Affairs survey actually show that Texans want regulation of the psychoactive cannabinoid.

The polling found that nearly 4 in 5 (79 percent) support legalizing the sale and use of medical marijuana with a doctor’s recommendation, while more than 3 in 5 (62 percent) support legalizing and regulating an adult-use cannabis market.

Almost 7 in 10 (69 percent), meanwhile, said they think the state should decriminalize marijuana for personal use.

There is bipartisan support in the survey for each of the reforms.

Keep reading

GOP Congressman Wants To Talk With RFK Jr. About How ‘Marijuana Is Harmful’ As Trump’s Cabinet Pick Heads To Confirmation Vote

A GOP congressman says it’s “definitely” time to have a talk with President Donald Trump’s pick for head of the U.S. Department of Health and Human Services (HHS) to convince him that “marijuana is harmful” and that the way to make Americans healthy is by “limiting” its use.

After Robert F. Kennedy Jr. was cleared in an initial confirmation vote in the Senate Finance Committee, Rep. Andy Harris (R-MD) told Marijuana Moment that he wanted to have a chat with the potential HHS secretary, who has previously voiced support for cannabis legalization prior to being selected for the top federal health role by Trump.

“Marijuana is harmful,” Harris said in an interview at the Capitol on Wednesday. “We should definitely have a talk with RFK Jr. I mean, the bottom line is: We should keep Americans healthy by limiting the use of marijuana.”

But Harris—a staunchly anti-cannabis lawmaker who has championed legislation to block adult-use marijuana sales in Washington, D.C.—expressed a softer tone when asked about the therapeutic potential of psychedelics, which is another issue that Kennedy has pushed.

The congressman said it “might be possible” that psychedelics could be used in the treatment of conditions such as post-traumatic stress disorder (PTSD).

“We may want to do some more research, but we don’t want to do what D.C. did, which is just make them widely available,” he said, referencing a voter-approved initiative to decriminalize certain psychedelics—which would not inherently increase availability given the lack of any regulated sales component of the reform.

Meanwhile, despite Harris’s apparent concerns about Kennedy’s history of advocating for cannabis legalization, the nominee said last week that he will defer to the Drug Enforcement Administration (DEA) on marijuana rescheduling if confirmed.

That could complicate rescheduling given the fact that the current acting administrator of DEA, Derek Maltz, has made multiple comments expressing hostility to cannabis reform.

Relatedly, prior to Kennedy’s written responses to the Finance Committee, Sen. Elizabeth Warren (D-MA) recently pressed Kennedy to reiterate his position on marijuana legalization amid the ongoing effort to federally reschedule cannabis.

Keep reading

New Mexico Bill Would Legalize Psilocybin Therapy In Supervised Medical Setting

Newly introduced bipartisan legislation in New Mexico would establish a therapeutic psilocybin program in the state, legalizing the active ingredient in psychedelic mushrooms for use in a supervised medical setting.

Under SB 219, titled the Medical Psilocybin Act, patients with certain qualifying conditions would be able access psilocybin and use it under the guidance of a licensed healthcare provider. Therapy would consist of a preparation session, an administration session and a follow-up integration session.

Text of the measure as introduced says the act’s purpose “is to allow the beneficial use of psilocybin in a regulated system for alleviating qualified medical conditions.”

Qualifying conditions under the bill include major treatment-resistant depression, PTSD, substance use disorders and end-of-life care, though the state Department of Health could approve additional conditions.

The state would also license psilocybin producers to grow mushrooms and process psilocybin. Synthetic psilocybin and synthetic analogs of the substance would not be allowed under the proposal.

The 18-page bill has five listed sponsors, including four Democrats and one Republican. It’s been referred to the Senate Tax, Business and Transportation Committee.

“The Medical Psilocybin Act creates a carefully designed framework for the Department of Health to establish a medical program for psilocybin use,” said lead sponsor Sen. Jeff Steinborn (D) in statement posted to social media. “Ensuring New Mexicans have access to every available treatment for serious behavioral health challenges is critical, and this proven therapy offers new hope for those in need.”

Republican sponsor Sen. Craig Brandt, meanwhile, said he’s “excited to be able to offer this breakthrough medical treatment to New Mexicans.”

“Medical psilocybin is proving to be effective in treating traumatic brain injuries, post-traumatic stress disorder (PTSD), depression, and other mental health conditions,” he said. “As a veteran I’m hopeful that this new medical option will provide help to my fellow veterans.”

The state health department would be responsible for establishing guidelines around training for clinicians and producers, including dosage, approved settings for administration, production and storage protocols and other best practices.

Keep reading

RC-135 Rivet Joint Surveillance Jet Just Flew Unprecedented Mission Off Mexico

AU.S. Air Force RC-135V Rivet Joint conducted a highly unusual flight in the Gulf of California between Mexico’s Baja Peninsula and the rest of that country yesterday, according to online flight tracking data. The strategic intelligence, surveillance, and reconnaissance (ISR) plane looks to have done the same today.

The Rivet Joint is one of America’s most capable intelligence-gathering assets and the appearance of one off the Mexican coast is a significant development. This comes amid a major increase in U.S. military support to operations along the border with Mexico under President Donald Trump and talk of unprecedented direct action by American forces against drug cartels, which you can read more about in this separate TWZ feature.

Flight tracking software shows RC-135V serial number 64-14845 flew southwest from Offutt Air Force Base in Nebraska to the skies over southern California on February 3. Offutt is home to the 55th Wing, which oversees the bulk of the Air Force’s Rivet Joint fleet along with an array of other ISR and highly specialized command and control aircraft. The jet then hooked south along the Pacific coast of the Baja Peninsula before flying up into the Gulf of California. The aircraft subsequently returned to Offutt following the same route, but in reverse.

Keep reading

Cocaine Outpaces Oil As Colombia’s Most Valuable Export

In a shocking development, Colombia’s cocaine production, for the 10th year straight, soared to a new record high. The UN Office on Drugs and Crime (UNODC) estimates that the year’s annual output grew 52% year over year to a startling 2,664 metric tons, the largest amount ever produced. Despite the government in the capital Bogota, with U.S. backing, committing substantial resources to disrupt what is now an economically crucial illicit industry in rural Colombia coca cultivation and cocaine manufacturing keeps spiraling higher. The booming cocaine trade drives heightened insecurity and corruption which are damaging key economic sectors, notably the fiscally vital petroleum industry with oil Colombia’s most valuable export.

Since the 1990s, except for a brief period from 2011 to 2012, Colombia has consistently been the world’s leading cultivator of the coca plant. The bushy shrub’s alkaloid-rich leaves, long chewed by Indigenous South Americans to boost energy and ward off altitude sickness, are the vital precursor needed to manufacture the popular recreational narcotic cocaine hydrochloride which is widely consumed in developed nations around the world. The volume of cocaine produced is spiraling ever higher despite Colombia, since the 1980s, waging a multi-billion-dollar U.S.-backed war on drugs, 

This conflict not only failed to stem the flow of cocaine but prolonged Colombia’s civil war and cost hundreds of thousands of Colombians (Spanish), mostly civilians, their lives. There are multiple reasons for this, but the key is the weakness of the Colombian state which is exacerbated by Bogota being caught in a protracted country-wide multiparty asymmetric conflict rooted in inequality, Cold War politics and foreign interference. Colombia’s widespread poverty and lawlessness create favorable conditions for the growth of illicit economies, such as smuggling, thereby allowing the cocaine trade to take root.

While the cocaine business has existed since the early 1970s in Colombia, it was the formation of the Medellin and Cali Cartels toward the end of that decade that put the Andean country firmly on the global map as a leading cocaine exporter. The vast profits cocaine generates caught the attention of a multitude of illegal armed groups across Latin America including those waging a vicious decades-long civil war in Colombia. This led to a significant escalation in the conflict among cartels, leftist guerrillas, and right-wing paramilitaries, all vying for control of the lucrative billion-dollar illicit industry. These events sparked a vicious cycle of escalating violence, which fueled further lawlessness thereby perpetuating the conditions that allowed the cocaine trade to thrive.

Surprisingly, large-scale cultivation of the coca plant did not occur in Colombia when the Medellin Cartel was at the peak of its power during the 1980s. Estimates put the amount of coca being cultivated during the mid-1980s at a mere 32,000 acres or 13,000 hectares, roughly a twentieth of what it is today. Both the Medellin and Cali Cartels, at the time the world’s largest suppliers of the drug, relied upon coca paste imported from Bolivia and Peru to manufacture the cocaine they were shipping to the U.S. and Europe. This changed as other illegal armed groups, particularly rightwing paramilitary death squads and the leftist Revolutionary Armed Forces of Colombia (FARC – Spanish initials) entered the fray. 

Keep reading

Ohio GOP Lawmakers Introduce Bill To Raise Marijuana Tax, Restrict Home Grow And Eliminate Social Equity Funding

Ohio Republican lawmakers are reviving an effort to significantly alter the state’s voter-approved marijuana legalization law—in part by raising the tax on cannabis products, halving the number of plants adults could grow and eliminating certain social equity provisions.

While GOP leadership has generally pledged that they will not seek to repeal the marijuana law altogether, a newly filed bill from Sen. Steve Huffman (R)—which the Senate president signaled he supports—would make major changes that substantially depart from the provisions of the initiative that voters strongly approved in 2023.

Among the proposed revisions, the bill would increase the excise tax on marijuana from 10 percent to 15 percent. And rather than have revenue allocated to specific areas supporting social equity and jobs programs, local governments that permit marijuana businesses, education and substance misuse initiatives and more, all revenue would instead go to the state general fund.

Senate President Rob McColley (R) told The Columbus Dispatch that legislators intend to discuss possible disbursements of that revenue this session, but he said he’s aligned with the bill sponsor on the idea of increasing the tax rate for cannabis.

“There’s an awful lot of societal costs that are going to have to be borne by the legalization of marijuana,” he said.

Under Huffman’s bill, adults would only be able to grow up to six plants, rather than 12, for personal use. It would also decrease the THC content cap from 90 percent to 70 percent.

Further, the proposal would limit the number of dispensaries to 350, while requiring all licensed retailers to serve both adult-use consumers and medical cannabis patients. The state Division of Cannabis Control (DCC) would also no longer be required to establish rules allowing for marijuana deliveries and online purchases.

GOP lawmakers considered a variety of potential amendments to the marijuana law in the weeks after voters passed the ballot initiative, and this latest attempt is likely to see similar pushback.

Sen. Bill DeMora (D) said during a committee hearing on Wednesday that the proposal effectively amounts to legislators telling voters: “Screw you, you don’t know what you’re talking about. You passed it with an overwhelming majority in the state, but we know better than they did what they were voting on.”

Huffman, the bill sponsor, said the legislation is not meant to “do away with the ballot initiative.”

“It’s to work around the edges to make it better,” he said.

Keep reading

Analysis: Steep Declines in Teen Marijuana Use in States With Regulated Cannabis Markets

Marijuana use by teens has fallen sharply in the majority of states that have legalized the adult-use market, according to an analysis of state and federal survey data by the Marijuana Policy Project.

MPP’s analysis acknowledges steady declines in self-reported marijuana use by young people in 19 of 21 states for which data is available. Federally funded survey data shows similar nationwide declines in teen marijuana use over the past decade.

“Over a decade into state-level cannabis legalization, the data is unequivocal: Legalization does not increase youth cannabis use. In fact, evidence suggests the opposite,” said Karen O’Keefe, Director of State Policies at the Marijuana Policy Project. “By transitioning cannabis sales from the illicit market to a regulated system with age-restricted access, we’ve seen a decrease in youth cannabis use.”

Last month, national data provided by the University of Michigan’s Monitoring the Future study reported that marijuana use by teens fell to historic lows in 2024. Specifically, it determined that the percentage of 8th graders, 10th graders, and 12 graders who reported having ever consumed cannabis declined 32 percent, 37 percent, and 23 percent since 2014.

Keep reading

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, the attorneys general from several states announced Thursday.

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, replaces a previous settlement deal that was rejected last year by the U.S. Supreme Court.

In the new one, the Sacklers agreed to pay up to $6.5 billion and give up ownership of the company, which would pay nearly $900 million. The maximum contribution from family members is $500 million more than the previous deal.

It’s among the largest settlements reached over the past several years in a series of lawsuits by local, state, Native American tribal governments and others seeking to hold companies responsible for a deadly epidemic. Aside from the Purdue deal, others worth around $50 billion have been announced — and most of the money is required to be used to stem the crisis.

The deal still needs court approval, and some of the details are yet to be ironed out. An arm of the federal Department of Justice opposed the previous settlement, even after every state agreed, and took the battle to the U.S. Supreme Court. But under President Donald Trump, the federal government is not expected to oppose the new deal.

Keep reading